Search Results

There are 5307 results for: content related to: Use of recombinant activated factor VII in J ehovah's W itness patients with critical bleeding

  1. You have free access to this content
    Activity and regulation of glycoPEGylated factor VIIa analogs

    Journal of Thrombosis and Haemostasis

    Volume 6, Issue 9, September 2008, Pages: 1525–1533, S. GHOSH, P. SEN, U. R. PENDURTHI and L. V. M. RAO

    Version of Record online : 4 JUL 2008, DOI: 10.1111/j.1538-7836.2008.03065.x

  2. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia

    Intervention Review

    The Cochrane Library

    Ewurabena Simpson, Yulia Lin, Simon Stanworth, Janet Birchall, Carolyn Doree and Chris Hyde

    Published Online : 14 MAR 2012, DOI: 10.1002/14651858.CD005011.pub4

  3. Effect of glycoPEGylation on factor VIIa binding and internalization

    Haemophilia

    Volume 16, Issue 2, March 2010, Pages: 339–348, P. SEN, S. GHOSH, M. EZBAN, U. R. PENDURTHI and L. VIJAYA MOHAN RAO

    Version of Record online : 21 OCT 2009, DOI: 10.1111/j.1365-2516.2009.02121.x

  4. Recombinant factor VIIa in paediatric bleeding disorders – a 2006 review

    Haemophilia

    Volume 12, Issue 5, September 2006, Pages: 457–472, P. MATHEW and G. YOUNG

    Version of Record online : 16 OCT 2006, DOI: 10.1111/j.1365-2516.2006.01321.x

  5. Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile

    Transfusion

    Volume 46, Issue 6, June 2006, Pages: 919–933, Jerrold H. Levy, Abe Fingerhut, Thomas Brott, Irene H. Langbakke, Elisabeth Erhardtsen and Robert J. Porte

    Version of Record online : 11 APR 2006, DOI: 10.1111/j.1537-2995.2006.00824.x

  6. You have free access to this content
    A systematic review of the cost-effectiveness of rFVIIa and APCC in the treatment of minor/moderate bleeding episodes for haemophilia patients with inhibitors

    Haemophilia

    Volume 15, Issue 2, March 2009, Pages: 405–419, C. KNIGHT, A. M. DANØ and T. KENNEDY-MARTIN

    Version of Record online : 1 FEB 2009, DOI: 10.1111/j.1365-2516.2008.01969.x

  7. You have free access to this content
    A novel approach to improving recombinant factor VIIa activity with a preserved platelet preparation

    British Journal of Haematology

    Volume 138, Issue 1, July 2007, Pages: 82–93, Robert A. Campbell, Thomas H. Fischer and Alisa S. Wolberg

    Version of Record online : 6 JUN 2007, DOI: 10.1111/j.1365-2141.2007.06617.x

  8. You have free access to this content
    Recombinant factor VIIa reverses the anticoagulant effect of the long-acting pentasaccharide idraparinux in healthy volunteers

    British Journal of Haematology

    Volume 124, Issue 5, March 2004, Pages: 653–658, Nick R. Bijsterveld, Roel Vink, Benien E. Van Aken, Hein Fennema, Ron J. G. Peters, Joost C. M. Meijers, Harry R. Büller and Marcel Levi

    Version of Record online : 2 FEB 2004, DOI: 10.1111/j.1365-2141.2003.04811.x

  9. You have full text access to this OnlineOpen article
    The evidence for the use of recombinant factor VIIa in massive bleeding: revision of the transfusion policy framework

    Transfusion Medicine

    Volume 22, Issue 6, December 2012, Pages: 383–394, Y. Lin, C. J. Moltzan, D. R. Anderson and on behalf of the National Advisory Committee on Blood and Blood Products

    Version of Record online : 27 MAY 2012, DOI: 10.1111/j.1365-3148.2012.01164.x

  10. You have full text access to this OnlineOpen article
    Endothelial cell protein C receptor-mediated redistribution and tissue-level accumulation of factor VIIa

    Journal of Thrombosis and Haemostasis

    Volume 10, Issue 11, November 2012, Pages: 2383–2391, C. A. CLARK, R. VATSYAYAN, U. HEDNER, C. T. ESMON, U. R. PENDURTHI and L. V. M. RAO

    Version of Record online : 30 OCT 2012, DOI: 10.1111/j.1538-7836.2012.04917.x

  11. Use of recombinant activated factor VII in the management of medical and surgical bleeding: a critical review

    Transfusion Alternatives in Transfusion Medicine

    Volume 8, Issue s1, December 2006, Pages: 66–80, MARIE E. STEINER and NIGEL S. KEY

    Version of Record online : 14 NOV 2006, DOI: 10.1111/j.1778-428X.2006.00033.x

  12. You have free access to this content
    Preferential localization of recombinant factor VIIa to platelets activated with a combination of thrombin and a glycoprotein VI receptor agonist

    Journal of Thrombosis and Haemostasis

    Volume 5, Issue 4, April 2007, Pages: 774–780, M. KJALKE, S. KJELLEV and R. ROJKJAER

    Version of Record online : 9 JAN 2007, DOI: 10.1111/j.1538-7836.2007.02389.x

  13. You have free access to this content
    Enhanced in vitro procoagulant and antifibrinolytic potential of superactive variants of recombinant factor VIIa in severe hemophilia A

    Journal of Thrombosis and Haemostasis

    Volume 1, Issue 10, October 2003, Pages: 2175–2178, T. Lisman, P. G. De Groot, T. Lambert, R. Røjkjær and E. Persson

    Version of Record online : 4 SEP 2003, DOI: 10.1046/j.1538-7836.2003.00444.x

  14. Utilization of recombinant activated factor VII in southern Ontario in 85 patients with and without haemophilia

    Haemophilia

    Volume 13, Issue 5, September 2007, Pages: 518–526, K. E. WEBERT, D. M. ARNOLD, J. CARRUTHERS, L. MOLNAR, T. ALMONTE, K. DECKER, W. SEROSKI, J. REED, A. K. CHAN, M. PAI and I. R. WALKER

    Version of Record online : 12 JUL 2007, DOI: 10.1111/j.1365-2516.2007.01490.x

  15. Single 270 μg kg−1-dose rFVIIa vs. standard 90 μg kg−1-dose rFVIIa and APCC for home treatment of joint bleeds in haemophilia patients with inhibitors: a randomized comparison

    Haemophilia

    Volume 14, Issue 2, March 2008, Pages: 287–294, G. YOUNG, F. E. SHAFER, P. ROJAS and S. SEREMETIS

    Version of Record online : 11 DEC 2007, DOI: 10.1111/j.1365-2516.2007.01601.x

  16. Synthesis and characterization of recombinant factor VIIa-conjugated magnetic iron oxide nanoparticles for hemophilia treatment

    Journal of Biomedical Materials Research Part A

    Volume 91A, Issue 4, 15 December 2009, Pages: 1056–1064, Gilead Shafir, Anna Galperin and Shlomo Margel

    Version of Record online : 23 DEC 2008, DOI: 10.1002/jbm.a.32296

  17. Control of bleeding in patients with haemophilia A with inhibitors: a systematic review

    Haemophilia

    Volume 9, Issue 4, July 2003, Pages: 464–520, M. Lloyd Jones, J. Wight, S. Paisley and C. Knight

    Version of Record online : 26 JUN 2003, DOI: 10.1046/j.1365-2516.2003.00782.x

  18. You have free access to this content
    Bio-distribution of pharmacologically administered recombinant factor VIIa (rFVIIa)

    Journal of Thrombosis and Haemostasis

    Volume 8, Issue 2, February 2010, Pages: 301–310, R. GOPALAKRISHNAN, U. HEDNER, S. GHOSH, R. C. NAYAK, T. C. ALLEN, U. R. PENDURTHI and L. V. M. RAO

    Version of Record online : 23 NOV 2009, DOI: 10.1111/j.1538-7836.2009.03696.x

  19. You have free access to this content
    Intravascular inhibition of factor VIIa and the analogue NN1731 by antithrombin

    British Journal of Haematology

    Volume 152, Issue 1, January 2011, Pages: 99–107, Lars C. Petersen, Ditte M. Karpf, Henrik Agersø, Mette B. Hermit, Hermann Pelzer, Egon Persson, Timothy C. Nichols and Mirella Ezban

    Version of Record online : 18 NOV 2010, DOI: 10.1111/j.1365-2141.2010.08432.x

  20. You have free access to this content
    Prerequisites for recombinant factor VIIa-induced thrombin generation in plasmas deficient in factors VIII, IX or XI

    Journal of Thrombosis and Haemostasis

    Volume 4, Issue 1, January 2006, Pages: 192–200, T. LIVNAT, A. ZIVELIN, U. MARTINOWITZ, O. SALOMON and U. SELIGSOHN

    Version of Record online : 13 DEC 2005, DOI: 10.1111/j.1538-7836.2005.01683.x